Complete Remission in a Patient with Metastatic Type 1 Gastric Carcinoid (GCA1) Treated with a Long-acting Somatostatin Analogue

#190

Introduction: Surgery is the treatment of choice for invasive and metastatic GCA1. Somatostatin analogues have been successfully used in GCA1 patients without signs of malignancy.

Aim(s): Here we report the first case of successful treatment of metastatic type 1 gastric carcinoid with a long-acting somatostatin analogue.

Materials and methods: Gastroscopy of a 55-year-old woman revealed an invasive carcinoid with surrounding chronic active gastritis. CT showed a 21 mm gastric polyp and two small lymph nodes. A 68Ga DOTATOC PET/CT showed uptake in the gastric polyp, one of the lymph nodes and in three small hepatic lesions. Serum gastrin, CgA and anti-parietal cell Ab's were elevated.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Fraenkel M, Barak D, Appelbaum L, Krausz Y, Gross D,

Keywords: metastatic type one gastric carcinoid, somatostatin analogue,

To read the full abstract, please log into your ENETS Member account.